Shirley Tan focuses on biotechnology patent prosecution. She has extensive technical experience in the areas of vaccines, pharmaceuticals, nutraceuticals, immunology, cannabinoid biology, molecular biology and medical devices.
Prior to joining Wolf Greenfield, Shirley was a patent agent at Cooley LLP in Washington DC, where she focused on the drafting and prosecution of domestic and international biotechnology patent applications, as well as assisting in the preparation of freedom to operate and patentability opinions.
Shirley’s doctoral research focused on elucidating the interactive effects of mitochondrial β-carotene 9', 10’-oxygenase and tomato phytochemicals on prostate carcinogenesis-related gene expression. After her graduate work, she undertook a postdoctoral fellowship at Johns Hopkins University School of Medicine. Her postdoctoral research focused on studying molecular signatures of subtypes of prostate cancer to identify diagnostic targets for developing personalized medicine.